| |
|
|
| Name: |
Ikarian Capital LLC |
| City: |
DALLAS |
| State: |
TX |
| Zip: |
75201 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
26 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CRNX |
Crinetics Pharmaceuticals, ... |
1 |
- |
$44.41 |
$30,134,000 |
643,751 |
8.2% |
5,926,000 |
-36,619 |
0.876 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
3 |
- |
$0.16 |
$24,200,000 |
565,411 |
6.58% |
443,000 |
-24,832 |
0.71 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
7 |
- |
$4.12 |
$10,559,000 |
1,564,340 |
2.87% |
-4,294,000 |
-426,665 |
1.609 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
8 |
- |
$64.97 |
$10,361,000 |
261,365 |
2.82% |
1,074,000 |
-225,883 |
0.399 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
9 |
- |
$0.00 |
$10,275,000 |
168,388 |
2.79% |
5,819,000 |
-31,612 |
0.321 |
N/A |
|
|
ANNX |
Annexon, Inc. |
11 |
- |
$0.00 |
$10,074,000 |
1,405,000 |
2.74% |
-1,957,000 |
-1,245,000 |
1.632 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
13 |
- |
$28.01 |
$8,720,000 |
282,013 |
2.37% |
-10,380,000 |
-191,113 |
0.162 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
17 |
- |
$0.00 |
$7,629,000 |
101,601 |
2.07% |
-11,368,000 |
-156,541 |
0.154 |
N/A |
|
|
LYRA |
Lyra Therapeutics, Inc. |
19 |
- |
$0.00 |
$6,573,000 |
1,056,829 |
1.79% |
0 |
-197,555 |
2.011 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
26 |
- |
$1.42 |
$4,863,000 |
537,925 |
1.32% |
-3,247,000 |
-208,144 |
0.966 |
N/A |
|
|
LRMR |
Larimar Therapeutics Inc |
31 |
- |
$1.15 |
$3,328,000 |
438,528 |
0.91% |
585,000 |
-164,340 |
1.098 |
N/A |
|
|
MNMD |
Mind Medicine |
34 |
- |
$8.80 |
$2,796,000 |
297,481 |
0.76% |
600,000 |
-302,519 |
0.837 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
40 |
- |
$10.42 |
$2,305,000 |
633,282 |
0.63% |
458,000 |
-589,570 |
0.292 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
44 |
- |
$9.47 |
$1,980,000 |
140,687 |
0.54% |
-899,000 |
-234,120 |
0.257 |
N/A |
|
|
VYGR |
Voyager Therapeutics, Inc. |
47 |
- |
$8.40 |
$1,684,000 |
180,857 |
0.46% |
-897,000 |
-125,000 |
0.483 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
48 |
- |
$33.95 |
$1,580,000 |
25,372 |
0.43% |
-9,682,000 |
-169,610 |
0.105 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
51 |
- |
$0.00 |
$1,382,000 |
101,325 |
0.38% |
-2,412,000 |
-245,146 |
0.267 |
N/A |
|
|
ABOS |
Acumen Pharmaceuticals, Inc. |
55 |
- |
$0.00 |
$1,079,000 |
266,435 |
0.29% |
-132,000 |
-48,830 |
0.658 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
56 |
- |
$10.36 |
$1,060,000 |
100,609 |
0.29% |
-645,000 |
-51,212 |
0.015 |
N/A |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
59 |
- |
$0.00 |
$941,000 |
331,451 |
0.26% |
-11,976,000 |
-546,049 |
0.491 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
63 |
- |
$4.02 |
$760,000 |
148,089 |
0.21% |
131,000 |
-1,023,850 |
0.349 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
67 |
- |
$6.01 |
$581,000 |
88,497 |
0.16% |
-493,000 |
-76,983 |
0.136 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
75 |
- |
$0.00 |
$92,000 |
6,816 |
0.03% |
28,000 |
-5,300 |
0.014 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
78 |
- |
$0.44 |
$22,000 |
1,047 |
0.01% |
-8,485,000 |
-367,083 |
0.001 |
Biotechnology |
|
|
TYRA |
Tyra Biosciences, Inc. |
80 |
- |
$0.00 |
$8,000 |
501 |
0% |
-659,000 |
-47,669 |
0.001 |
N/A |
|
|
LBPH |
Longboard Pharmaceuticals, ... |
82 |
- |
$0.00 |
$5,000 |
236 |
0% |
-5,901,000 |
-979,226 |
0.001 |
N/A |
|
